Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Imuran Tablets°


Contraindicated
Leucopenia and/or thrombocytopenia in neonates whose mother were treated

Contraindicated
Imuran Tablets° :
Type Medicine Withdrawn
Originator B
Agent Abela Freres
Distributor Abela Freres
Laboratory Aspen
Manufacturer Excella GmbH
Origin Germany
ATC L04AX01

Your comment will appear shortly after approval

Imuran Tablets° :

Revision Date : 01/02/2017


Effect Frequency
Acute myeloid leukaemia Rare
Agranulocytosis Rare
Alopecia Rare
Anaemia Uncommon
Anaemia megaloblastic Rare
Aplastic anemia Rare
Bacterial infection Very Common
Bone marrow failure Very Common
Cervical cancer Rare
Cholestasis Uncommon
Colitis Rare
Diarrhoea (Diarrhea) Rare
Diverticulitis Rare
Fungal infection Very Common
Hepatic damage Rare
Hypersensitivity reactions Uncommon
Hypoplasia erythroid Rare
Kaposi's sarcoma Rare
Leucopenia (Leukopenia) Very Common
Liver function test abnormal Uncommon
Lyell Syndrome (Toxic epidermal necrolysis) Very rare
Lymphoproliferative disorder Rare
Melanoma recurrent Rare
Myelodysplasia Rare
Neoplasm Rare
Pancreatitis Uncommon
Pancytopenia Rare
Photosensitivity Rare
Pneumonitis Very rare
Sarcoma Rare
Skin carcinoma (Skin cancer) Rare
Stevens-Johnson syndrome Very rare
Thrombocytopenia (Thrombopenia) Common
Uterine cancer Rare
Viral infection Very Common

Different Units By MoH Code

Revision Date : 22/06/2012

Imuran Tablets°  MoH 6046 :
Form Tablet, Film-Coated
Packaging Blisters
Package Size Box of 100
Strength 50mg
Storage Condition <25°C protect from light
Stratum N/A
NSSF ✘
Quarantine ✘
Reg. Number 167099/10
Submission date 01/01/2010
Registration Year 2010
Withdrawn Date 2014


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info